Article Details
Retrieved on: 2021-05-03 18:11:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Eiger Biopharmaceuticals (EIGR) stock is higher today after the company announced that its lead clinical drug, Peginterferon Lambda (Lambda), will ...
Article found on: www.investorsobserver.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here